SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-118014
Filing Date
2019-04-25
Accepted
2019-04-25 07:39:32
Documents
7
Effectiveness Date
2019-04-25

Document Format Files

Seq Description Document Type Size
1 DEFA14A d666807ddefa14a.htm DEFA14A 34036
2 GRAPHIC g666807g05e15.jpg GRAPHIC 23408
3 GRAPHIC g666807g16q56.jpg GRAPHIC 13701
4 GRAPHIC g666807g27h54.jpg GRAPHIC 36548
5 GRAPHIC g666807g62d05.jpg GRAPHIC 24728
6 GRAPHIC g666807g76c99.jpg GRAPHIC 32714
7 GRAPHIC g666807g87n84.jpg GRAPHIC 13084
  Complete submission text file 0001193125-19-118014.txt   234328
Mailing Address 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 29 HARTWELL AVENUE LEXINGTON MA 02421 617-945-7361
Translate Bio, Inc. (Filer) CIK: 0001693415 (see all company filings)

IRS No.: 611807780 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38550 | Film No.: 19765385
SIC: 2836 Biological Products, (No Diagnostic Substances)